EUVIMEDEUVIMED entdecken
Crossref

Vitiligo: current concepts of pathogenesis, genetics, biomarkers, and innovative treatment approaches

Jihen Amami, Elena E. Zhiltsova

Russian Journal of Skin and Venereal Diseases · 28.05.2026 · 29 (3) · 345-356

DOI: 10.17816/dv686366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Russian Journal of Skin and Venereal Diseases, online erschienen am 28.05.2026. Verfasst von Jihen Amami und 1 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is a chronic autoimmune skin disease characterized by progressive destruction of melanocytes, the mechanisms of which have long remained poorly understood. Despite significant advances in understanding certain aspects of the disease, until recently, a comprehensive picture of the molecular basis of vitiligo and effective therapeutic approaches was lacking. The need to systematize the latest data on the genetic, immunological, and therapeutic aspects of the disease prompted this review of current research. This search and analytical review of studies published between 2020 and 2025 has revealed revolutionary changes in our understanding of vitiligo pathogenesis. Genome-wide association studies have identified 54 gene loci associated with the disease, with familial and SNP heritability estimates of 0.75–0.83 and 0.78, respectively, indicating that the genetic architecture of the disease has been almost completely defined. The key role of cytotoxic CD8+ T lymphocytes in the selective destruction of melanocytes via the perforin-granzyme pathway and the interferon-γ-induced chemokine loop CXCL10-CXCR3 has been established. Novel biomarkers have been identified, including the transcription factor NFATC1, FOXP3 promoter polymorphisms, and NKG2D+ memory CD8+ T cells. Clinical trials demonstrate the breakthrough potential of JAK inhibitors, with topical ruxolitinib showing efficacy through suppression of local immune autoreactivity and tofacitinib providing systemic effects through blockade of interferon-γ signaling. The presented analysis systematizes, for the first time, current data on the complete genetic architecture of vitiligo, new molecular biomarkers, and revolutionary therapeutic approaches, including the concept of enhancing the PD-1/PD-L1 axis and CAR-Treg therapy, which opens up prospects for personalized diagnosis and pathogenetically based treatment of the disease.

Zitieren

APA

Amami, J., & Zhiltsova, E. E. (2026). Vitiligo: current concepts of pathogenesis, genetics, biomarkers, and innovative treatment approaches. Russian Journal of Skin and Venereal Diseases, 29(3), 345-356. https://doi.org/10.17816/dv686366

Vancouver

Amami J, Zhiltsova EE. Vitiligo: current concepts of pathogenesis, genetics, biomarkers, and innovative treatment approaches. Russian Journal of Skin and Venereal Diseases. 2026;29(3):345-356. doi:10.17816/dv686366

BibTeX
@article{Amami2026,
  author = {Amami, Jihen and Zhiltsova, Elena E.},
  title = {Vitiligo: current concepts of pathogenesis, genetics, biomarkers, and innovative treatment approaches},
  journal = {Russian Journal of Skin and Venereal Diseases},
  year = {2026},
  volume = {29},
  number = {3},
  pages = {345--356},
  doi = {10.17816/dv686366}
}
Kostenlos starten →